CKH's NAV discount and implied stub are elevated. And elevated vs. CKI. At a forward P/B of 0.36x, CKH remains cheap. Yet expect weakness near term if the exclusivity ends without any resolution.
What is covered in the Full Insight:
Introduction
Geopolitical Challenges
Market and Financial Overview
Potential Outcomes
Long-term Strategy and Conclusion
Boomeranged on Mon, 28 Jul 2025 08:31
The exclusivity ha expired, however CKH "remains in discussions with... the consortium with a view to inviting major strategic investor from the PRC to join as a significant member ... needed for the transaction to be ... approved by all relevant authorities". Sounds like much-rumoured Cosco joining. A <50% stake, you would think, should keep all & sundry happy.